Hbk Sorce Advisory LLC Abbott Laboratories Transaction History

Hbk Sorce Advisory LLC

$2.56 Billion
Q3 2024

A detailed history of Hbk Sorce Advisory LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Hbk Sorce Advisory LLC holds 24,637 shares of ABT stock, worth $2.84 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

24,637

Previous 25,457 3.22%

Holding current value

$2.84 Million

Previous $2.65 Million 6.16%

% of portfolio

0.11%

Previous 0.1%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $82,057 - $96,866	-820 Reduced 3.22%	24,637 $2.81 Million
Q2 2024 Aug 08, 2024	BUY	$100.73 - $112.44 $159,052 - $177,542	1,579 Added 6.61%	25,457 $2.65 Million
Q1 2024 May 09, 2024	BUY	$109.52 - $120.96 $1,642 - $1,814	15 Added 0.06%	23,878 $2.71 Million
Q4 2023 Jan 25, 2024	BUY	$90.19 - $110.4 $630,067 - $771,254	6,986 Added 41.39%	23,863 $2.63 Million
Q3 2023 Nov 06, 2023	SELL	$95.53 - $114.62 $158,388 - $190,039	-1,658 Reduced 8.95%	16,877 $1.63 Million
Q2 2023 Aug 04, 2023	SELL	$100.78 - $112.29 $1.67 Million - $1.86 Million	-16,558 Reduced 47.18%	18,535 $2.02 Million
Q1 2023 Aug 15, 2023	SELL	$96.86 - $114.01 $117,297 - $138,066	-1,211 Reduced 6.53%	17,324 $1.75 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $80,490 - $94,742	-831 Reduced 2.31%	35,093 $5.35 Million
Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $1.65 Million - $1.94 Million	17,391 Added 93.84%	35,924 $3.94 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $847,520 - $981,270	8,759 Added 89.62%	18,533 $1.79 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $930,674 - $1.12 Million	-9,118 Reduced 48.26%	9,774 $1.06 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $56,211 - $68,546	-493 Reduced 2.54%	18,892 $2.24 Million
Q4 2021 Feb 15, 2022	BUY	$115.53 - $141.46 $314,357 - $384,912	2,721 Added 16.33%	19,385 $2.73 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $270,884 - $299,677	2,322 Added 16.19%	16,664 $1.97 Million
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $17,878 - $21,045	169 Added 1.19%	14,342 $1.66 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $44,189 - $52,061	406 Added 2.95%	14,173 $1.7 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $47,460 - $51,717	452 Added 3.39%	13,767 $1.51 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $611,605 - $742,749	-6,674 Reduced 33.39%	13,315 $1.45 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $177,029 - $226,576	-2,312 Reduced 10.37%	19,989 $1.83 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $17,338 - $25,353	276 Added 1.25%	22,301 $1.76 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $162,986 - $181,442	2,076 Added 10.41%	22,025 $1.91 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $159,260 - $172,688	-1,946 Reduced 8.89%	19,949 $1.67 Million
Q2 2019 Aug 15, 2019	BUY	$72.88 - $85.0 $905,461 - $1.06 Million	12,424 Added 131.18%	21,895 $1.84 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $1.18 Million - $1.38 Million	-16,250 Reduced 63.18%	9,471 $372,000
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $41,122 - $49,717	621 Added 2.47%	25,721 $2.06 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $307,148 - $347,954	4,685 Added 22.95%	25,100 $1.82 Million
Q3 2018 Nov 15, 2018	BUY	$60.81 - $73.36 $3,283 - $3,961	54 Added 0.27%	20,415 $1.5 Million
Q2 2018 Aug 10, 2018	BUY	$57.57 - $63.54 $61,599 - $67,987	1,070 Added 5.55%	20,361 $0
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $192,105 - $217,198	-3,414 Reduced 15.04%	19,291 $1.16 Million
Q4 2017 Feb 15, 2018	BUY	$53.68 - $57.47 $592,788 - $634,641	11,043 Added 94.69%	22,705 $1.3 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $560,475 - $625,549	11,662	11,662 $622,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $202B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hbk Sorce Advisory LLC with notifications on news.

Account

Hbk Sorce Advisory LLC Abbott Laboratories Transaction History